INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2020

Resveratrol supplementation improved cognitive performance and attenuated the decline in cerebrovascular responsiveness in postmenopausal women.

Postmenopausal women aged 45-85 years (n = 129) were randomized to receive placebo or 75 mg trans-resveratrol twice daily for 12 months. Compared to placebo, resveratrol improved overall cognitive performance (P < 0.001) and attenuated the decline in cerebrovascular responsiveness (CVR) to cognitive stimuli (P = 0.038). The attenuation of CVR decline was associated with a reduction of fasting blood glucose (r = -0.339, P = 0.023).

Study type
Randomized controlled trial
Who was studied
129 postmenopausal women aged 45-85 years
What was measured
Cognition, cerebral blood flow, cerebrovascular responsiveness (CVR), and cardiometabolic markers

THE PAPER

Sustained Cerebrovascular and Cognitive Benefits of Resveratrol in Postmenopausal Women.

Thaung Zaw JJ, Howe PRC, Wong RHX. Nutrients, 2020.

PubMed 32244933 ↗DOI 10.2337/db07-1750 ↗

Nutrients & adequacyBrain & moodHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.